276 related articles for article (PubMed ID: 11604353)
21. [Ex vivo expansion of hematopoietic stem cells: concept and clinical benefit].
Ivanovic Z; Boiron JM
Transfus Clin Biol; 2009; 16(5-6):489-500. PubMed ID: 19932632
[TBL] [Abstract][Full Text] [Related]
22. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity.
Boiron JM; Dazey B; Cailliot C; Launay B; Attal M; Mazurier F; McNiece IK; Ivanovic Z; Caraux J; Marit G; Reiffers J
Transfusion; 2006 Nov; 46(11):1934-42. PubMed ID: 17076849
[TBL] [Abstract][Full Text] [Related]
23. [The use of peripheral blood progenitor cells as an autologous hematopoietic support in high-dose chemotherapy. I. The rationale and results].
Silva MR; Passos-Coelho JL; da Costa FL; Machado MA; Miranda N; Miranda MH; Parreira A
Acta Med Port; 1999; 12(7-11):265-73. PubMed ID: 10707464
[TBL] [Abstract][Full Text] [Related]
24. [Use of recombinant hematopoietic growth factors in autologous bone marrow transplantation and peripheral blood stem cell transplantation].
Hołowiecki J
Acta Haematol Pol; 1994; 25(2 Suppl 1):95-103. PubMed ID: 8067214
[TBL] [Abstract][Full Text] [Related]
25. [Novel autograft method using positive selection of CD34 stem cells].
Lambermont M; Pradier O; Delville JP; Quinet C; Bastin G; Marblie S; Capel P; Dupont E; Le Moine F; Gangji D
Rev Med Brux; 1995 Nov; 16(5):372, 375-8. PubMed ID: 7501915
[TBL] [Abstract][Full Text] [Related]
26. Peripheral blood stem cell transplantations: past, present and future.
Hénon PR
Stem Cells; 1993 May; 11(3):154-72. PubMed ID: 8100462
[TBL] [Abstract][Full Text] [Related]
27. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
[TBL] [Abstract][Full Text] [Related]
28. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
[TBL] [Abstract][Full Text] [Related]
29. Stem cell selection--clinical experience.
Berenson RJ; Bensinger WI; Hill R; Andrews RG; Garcia-Lopez J; Kalamasz DF; Still BJ; Buckner CD; Bernstein ID; Thomas ED
Prog Clin Biol Res; 1990; 333():403-10; discussion 411-3. PubMed ID: 1689855
[TBL] [Abstract][Full Text] [Related]
30. Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy.
Blystad AK; Delabie J; Kvaløy S; Holte H; Vålerhaugen H; Ikonomou I; Kvalheim G
Br J Haematol; 2004 Jun; 125(5):605-12. PubMed ID: 15147376
[TBL] [Abstract][Full Text] [Related]
31. Clinical applications of ex vivo cultured CD34+ cells and myeloid progenitors.
Zimmerman TM; Williams SF
Cytokines Cell Mol Ther; 1998 Dec; 4(4):257-64. PubMed ID: 10068059
[TBL] [Abstract][Full Text] [Related]
32. [The use of peripheral blood progenitor cells as an autologous hematopoietic support in high-dose chemotherapy. II. The experience of the Hematological Intensive Care Unit of the IPOFG. Franciso Gentil Portuguese Institute of Oncology].
Silva MR; Passos-Coelho JL; da Costa FL; Machado MA; Miranda N; Miranda MH; Parreira A
Acta Med Port; 1999; 12(7-11):275-81. PubMed ID: 10707465
[TBL] [Abstract][Full Text] [Related]
33. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
Michallet M; Dhedin N; Michallet AS
Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
[TBL] [Abstract][Full Text] [Related]
34. [Ex vivo procedures associated with autologous hematopoietic stem cell transplantation].
Fernández M; Minguell JJ
Rev Med Chil; 1994 Jun; 122(6):699-704. PubMed ID: 7732217
[TBL] [Abstract][Full Text] [Related]
35. Technology evaluation: Stem-cell therapy, Aastrom Biosciences Inc.
Morse MA
Curr Opin Mol Ther; 1999 Dec; 1(6):745-52. PubMed ID: 19629872
[TBL] [Abstract][Full Text] [Related]
36. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
37. Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL.
Flohr T; Hess G; Kolbe K; Gamm H; Nolte H; Stanislawski T; Huber C; Derigs HG
Bone Marrow Transplant; 2002 May; 29(9):769-75. PubMed ID: 12040475
[TBL] [Abstract][Full Text] [Related]
38. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
[TBL] [Abstract][Full Text] [Related]
39. Stem cell purging: an intriguing dilemma.
Rizzoli V; Carlo-Stella C
Exp Hematol; 1995 Apr; 23(4):296-302. PubMed ID: 7895779
[TBL] [Abstract][Full Text] [Related]
40. New developments in stem cell detection and stem cell selection in the context of autologous transplantations.
Douay L; Lopez M; Giarratana MC; Bony V; Bouchet S; Gorin NC
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):87-9. PubMed ID: 8099734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
